Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO study-Reference-Cited by-同舟云学术

Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO study

Published:2013-01 Issue:1 Volume:58 Page:81-88
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Zaanan Aziz,Williet Nicolas,Hebbar Mohamed,Dabakuyo Tienhan Sandrine,Fartoux Laetitia,Mansourbakht Touraj,Dubreuil Olivier,Rosmorduc Olivier,Cattan Stéphane,Bonnetain Franck,Boige Valérie,Taïeb Julien

Publisher

Elsevier BV

Subject

Hepatology

Reference33 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007

3. Steatosis and hepatocellular carcinoma risk;Smedile;Eur Rev Med Pharmacol Sci,2005

4. Medical treatments for hepatocellular carcinoma (HCC): what’s next?;Taieb;Ann Oncol,2006

5. Hepatocellular carcinoma (HCC): an update;Rougier;Semin Oncol,2007

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationships Among Serological Indicators and In Vitro High-Throughput Drug Sensitivity Screening Results in Patients with Hepatocellular Carcinoma;Combinatorial Chemistry & High Throughput Screening;2024-06-26

2. Complete Pathologic Response to Gemcitabine and Oxaliplatin Chemotherapy After Prior Therapies in a Patient With Hepatocellular Carcinoma and Peritoneal Metastases Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;World Journal of Oncology;2024-06

3. Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case–control study;Liver International;2023-11-30

4. The worthy role of hepatic arterial infusion chemotherapy in combination with anti-programmed cell death protein 1 monoclonal antibody immunotherapy in advanced hepatocellular carcinoma;Frontiers in Immunology;2023-10-31

5. Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma;BMC Cancer;2023-08-29